1. P255 Mirikizumab modulates genes associated with the symptom of bowel urgency. (21st January 2022) Authors: Krishnan, G; Steere, B; Higgs, R; Wang, Y C; Harris, C J; Milch, C; Escobar, R; Reinisch, W; Dubinsky, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P554 Extended induction response in patients treated with mirikizumab with moderately to severely active ulcerative colitis in the LUCENT trials. (30th January 2023) Authors: D'Haens, G; Higgins, P D R; Peyrin-Biroulet, L; Sands, B E; Lee, S; Moses, R E; Redondo, I; Escobar, R; Morris, N; Kobayashi, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗